CClinicalTrials.gg
CompletedNCT01419223Updated Oct 29, 2013

Patient Participation Beliefs and Post-Traumatic Stress Disorder (PTSD)

An observational study in Post-Traumatic Stress Disorder and Brain Injuries, Traumatic, sponsored by INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-10-29.

Sponsored by INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

This is an exploratory qualitative interview study being conducted with a primary objective of examining perceptions held by active military and veterans regarding help-seeking attitudes and mental health beliefs which influence the decision to consent or decline participation in Post-Traumatic Stress Disorder (PTSD) or Traumatic Brain Injury (TBI) clinical trials. Active duty military and/or veterans aged 18 years and older who consent to participate (N = 50), or have recently declined participation (N = 50), in an INTRuST affiliated outpatient clinical trial for deployment-related PTSD or TBI will be recruited. Participants who consent to participate in an INTRuST clinical trial (Group 1) will be interviewed once at the beginning the of the clinical trial, and again following participation in the trial. Participants who decline participation in an INTRuST affiliated outpatient clinical trial (Group 2) will be interviewed once. For participants in both groups, study participation will initiate within 1 month of referral to study. Total duration of study participation is based on the specific clinical trial that the participant is recruitment from; the longest trial is estimated to be 24 weeks or less. Semi-structured qualitative individual interviews will be conducted to carry out a thematic analysis of the data exploring familial, social and institution-level constructs which may influence the subjective experience of the research treatment process.

02

Conditions studied

  • Post-Traumatic Stress Disorder
  • Brain Injuries, Traumatic

Keywords

  • Qualitative research
  • Health Knowledge, Attitudes, Practice
  • Refusal to Participate
03

In context

Brain Injuries

2,113 studies on the registry are indexed under Brain Injuries; 385 are open to participants now.

This study's enrollment of 30 is below the median of 100 across 690 observational studies indexed under Brain Injuries.

Browse Brain Injuries studies →

Lead sponsor

INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium is the lead sponsor of 10 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Active military and/or veterans ages 18 or over who have recently considered participating in an outpatient clinical trial for PTSD or TBI.

Eligibility criteria

Inclusion Criteria:

  1. Age between 18 and over
  2. Active duty and/or veteran
  3. Referred to participate in INTRuST-affiliated outpatient clinical trials for PTSD or TBI
  4. Ability to provide written informed consent
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
30 participants (actual)

Groups and cohorts

  • Consent to participate (Group 1)

    Active military and veterans who consent to participate in an INTRuST PTSD or TBI research trial.

  • Decline to participate (Group 2)

    Active military and veterans who decline to participate in an INTRuST PTSD or TBI research trial.

06

What researchers measure

Primary outcomes

  1. Perceptions about participation in clinical trials for PTSD or TBI as measured via qualitative interview.

    Perceptions regarding help-seeking attitudes and mental health beliefs which influence the decision to consent or decline participation in clinical treatment trials for PTSD-TBI will be measured via serial qualitative interview framework.

    Time frame: Qualitative interviews will be conducted during an expected average time frame of 12-24 weeks per study participant based on the specific study recruited from.

Secondary outcomes

  1. Feasibility of conducting qualitative interviews with active duty military and veterans who consent or decline participation in a PTSD or TBI clinical trial as measured by study participation.

    Feasibility will be determined by the number of participants anticipated vs. the number actually enrolled in the current study.

    Time frame: End of 21-month study recruitment period

07

Study locations

1 site
  • University of California San Diego
    La Jolla, California 92093, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 29, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01419223
Lead sponsor
INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium
Collaborators
U.S. Army Medical Research and Development Command
Responsible party
Sponsor
First posted
Aug 18, 2011
Start date
Jul 2011
Primary completion
Sep 2013
Completion
Sep 2013
Last update
Oct 29, 2013

Study contacts

Samantha Hurst, Ph.D.
principal investigator · University of California, San Diego

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion